Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange ...
Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution: Deer Park, Illinois Monday, February 10, 2025, 11:00 Hr ...
21h
Hosted on MSNToxins in a Michigan town may be making residents sick. Researchers will investigate.Cancer survivor Mary Zack started a campaign six years ago to find what’s making people sick in her hometown. State and federal officials descended on the small Southwest Michigan town of Otsego, ...
Transient diabetes insipidus almost always begins within 24-48 h of surgery, and usually abates within several days. Both transient diabetes insipidus and the first phase of the triphasic pattern ...
2d
GlobalData on MSNEton secures US patent for diabetes insipidus treatmentDesmopressin is approved in various forms, but these do not meet the paediatric need for precise, titratable and small doses.
People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...
A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
He suggests that adherence to the diet could lead to a reduced need for diabetes medication, stating: "I would say the more a person has a disorder or a disease that benefits from ketosis ...
How CGM sensors work and how to look after them Use of Continuous Glucose Monitors by People With and Without Diabetes New continuous glucose monitoring system to transform diabetes care First author ...
Dr. Medha N. Munshi, geriatrician and endocrinologist at BIDMC leads research on improving care for older adults with diabetes using digital technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results